Biological Psychiatry

Scope & Guideline

Exploring the intersection of biology and psychiatry for better mental health.

Introduction

Immerse yourself in the scholarly insights of Biological Psychiatry with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0006-3223
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1969 to 2024
AbbreviationBIOL PSYCHIAT / Biol. Psychiatry
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The journal 'Biological Psychiatry' focuses on the intersection of biological and psychiatric research, emphasizing the biological underpinnings of mental health disorders. It aims to advance the understanding of mental illness through a variety of biological approaches, ranging from genetic and neuroimaging studies to pharmacological and psychotherapeutic interventions.
  1. Neurobiological Mechanisms of Mental Disorders:
    The journal publishes research that investigates the neurobiological mechanisms underlying various psychiatric disorders, including schizophrenia, depression, and anxiety. This includes studies on neurotransmitter systems, neuroinflammation, and the impact of genetic variations on brain function.
  2. Translational Research and Treatment Innovations:
    A significant focus is placed on translational research that bridges laboratory findings with clinical applications. This includes studies on novel pharmacological treatments, the use of neuromodulation techniques like transcranial magnetic stimulation (TMS), and the exploration of biomarkers to predict treatment response.
  3. Psychiatric Genetics and Epigenetics:
    The journal also emphasizes the genetic and epigenetic factors contributing to mental health disorders. Research often involves genome-wide association studies (GWAS) and investigates how environmental factors interact with genetic predispositions to influence psychiatric outcomes.
  4. Neuroimaging and Brain Connectivity:
    Studies employing advanced neuroimaging techniques to examine brain structure and function are prevalent. This includes functional MRI (fMRI), diffusion tensor imaging (DTI), and PET scans to explore brain connectivity patterns associated with various psychiatric conditions.
  5. Psychosocial and Environmental Influences:
    Research exploring the impact of psychosocial factors, such as childhood adversity, socioeconomic status, and discrimination on mental health outcomes, is also a core area of interest. This includes studies examining how these factors interact with biological mechanisms.
Recent publications in 'Biological Psychiatry' indicate a shift towards innovative and interdisciplinary research approaches. This section outlines the emerging themes that have gained traction in the journal's recent issues.
  1. Machine Learning and AI in Psychiatry:
    There is a growing trend of utilizing machine learning and artificial intelligence to analyze complex psychiatric data, predict treatment outcomes, and personalize interventions based on individual patient profiles.
  2. Gut-Brain Axis Research:
    Research exploring the gut-brain axis and its implications for mental health is on the rise. This includes studies on microbiome alterations and their association with psychiatric symptoms, highlighting a novel area of investigation in mental health.
  3. Psychedelic-Assisted Therapies:
    The exploration of psychedelics as potential therapeutic agents for various mental health disorders is gaining momentum. Studies investigating the neurobiological effects and therapeutic potential of substances like psilocybin and MDMA are increasingly featured.
  4. Neuroinflammation and Immune System Interactions:
    An emerging focus on the role of neuroinflammation and immune system interactions in the pathophysiology of psychiatric disorders is evident. This includes research linking inflammatory markers with depression, anxiety, and PTSD.
  5. Neurodevelopmental Perspectives on Psychiatric Disorders:
    There is a trend towards understanding psychiatric disorders through a neurodevelopmental lens, focusing on how early-life experiences, genetics, and neurobiological factors contribute to the onset and progression of mental illnesses.

Declining or Waning

While 'Biological Psychiatry' continues to expand its focus on emerging areas of research, some traditional themes appear to be waning in prominence. This section highlights these declining scopes based on recent publication trends.
  1. Traditional Psychotherapy Approaches:
    Research focusing solely on conventional psychotherapy methods without a biological or neurobiological perspective has seen a decrease. The journal is increasingly prioritizing studies that integrate biological insights with therapeutic approaches.
  2. Basic Behavioral Studies Without Biological Correlates:
    There has been a noticeable decline in the publication of studies that examine basic behavioral phenomena in isolation, without linking them to underlying biological mechanisms. The emphasis is on understanding the biological basis of behaviors rather than descriptive studies.
  3. Epidemiological Studies Lacking Biological Insights:
    Epidemiological studies that do not incorporate biological or genetic factors are becoming less frequent. The journal is shifting towards integrative approaches that combine epidemiology with biological and genetic analysis to offer a more comprehensive understanding of mental health disorders.

Similar Journals

Neuropsychopharmacology Reports

Fostering collaboration in the realm of mental health and pharmacology.
Publisher: WILEYISSN: Frequency: 4 issues/year

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Brain Imaging and Behavior

Advancing Insights: Bridging Imaging Techniques and Neuroscience
Publisher: SPRINGERISSN: 1931-7557Frequency: 6 issues/year

Brain Imaging and Behavior is a premier journal published by SPRINGER, dedicated to advancing the understanding of the relationship between brain function and behavior through innovative imaging techniques. Since its inception in 2007, the journal has provided a crucial platform for researchers and professionals in fields such as Behavioral Neuroscience, Cognitive Neuroscience, and Psychiatry and Mental Health. With an impressive ranking within the Q1 category in Radiology, Nuclear Medicine and Imaging and maintaining strong Q2 status in several other categories, the journal is positioned as a leading resource for groundbreaking research. The journal aims to disseminate high-quality studies that explore neurobiological underpinnings of behavior, utilizing cutting-edge imaging technologies. Although it is not an open-access journal, the visibility and impact of published works in Brain Imaging and Behavior continue to influence the scientific community significantly, underscoring the critical intersection between imaging science and neuroscience.

JAMA Psychiatry

Elevating Standards in Mental Health through Scholarly Work
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

EUROPEAN PSYCHIATRY

Innovating Psychiatric Practices for a Better Tomorrow
Publisher: CAMBRIDGE UNIV PRESSISSN: 0924-9338Frequency: 1 issue/year

EUROPEAN PSYCHIATRY, published by Cambridge University Press, stands at the forefront of advancements in the field of psychiatry and mental health, serving as a vital resource for researchers, professionals, and students alike. With an impressive Q1 ranking in Psychiatry and Mental Health and an impact factor that underscores its significance, this journal fosters innovative studies and discussions that shape contemporary understanding of mental health issues. Offering Open Access since 2020, it ensures that high-quality research is readily available to a global audience, bridging gaps in knowledge dissemination. The journal, which has been publishing since 1991, encompasses a broad range of topics relevant to mental health, emphasizing evidence-based practices and interdisciplinary approaches to treatment and care. With its ongoing commitment to excellence, EUROPEAN PSYCHIATRY continues to be an indispensable platform for advancing the science of mental health.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Transforming Understanding in Psychiatry and Clinical Neuroscience
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

ACTAS ESPANOLAS DE PSIQUIATRIA

Fostering collaboration in psychiatric research and practice.
Publisher: JUAN JOSE LOPEZ-IBOR FOUNDATIONISSN: 1139-9287Frequency: 6 issues/year

ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.

Frontiers in Psychiatry

Innovating Solutions for Mental Well-being
Publisher: FRONTIERS MEDIA SAISSN: 1664-0640Frequency: 1 issue/year

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

Brazilian Journal of Psychiatry

Fostering excellence in psychiatry for a global audience.
Publisher: ASSOC BRASILEIRA PSIQUIATRIAISSN: 1516-4446Frequency: 4 issues/year

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

HARVARD REVIEW OF PSYCHIATRY

Transforming insights into impactful mental health practices.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1067-3229Frequency: 6 issues/year

HARVARD REVIEW OF PSYCHIATRY is a prestigious academic journal focused on the field of psychiatry and mental health, published by Lippincott Williams & Wilkins. Established in 1993, this journal has become a critical resource for researchers, clinicians, and students alike, providing cutting-edge insights and scholarly articles that address contemporary issues in mental health. With an impressive impact factor reflected in its Q1 ranking in Psychiatry and Mental Health, the journal ranks #90 out of 567 in its category in Scopus, placing it in the top 16% of publications in this field. The journal is dedicated to disseminating high-quality research and fostering dialogue among professionals, thus contributing significantly to the advancement of psychiatric sciences. Researchers can access the journal through traditional subscriptions, ensuring that vital knowledge and innovative practices are shared among a global audience.

BMC Psychiatry

Elevating psychiatric research to new heights.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.